guideline for prescribing opioids for chronic pain
/in Uncategorized /by adminPlease reply to this post with a minimum of two paragraphs with two references, APA Style, and no plagiarism.
-The management of acute and chronic pain often includes opioid therapy. In both the acute and chronic pain settings, however, opioids have several disadvantages including risk of nausea and vomiting, somnolence, constipation, respiratory depression, androgen deficiency, physical dependence, and tolerance. Opioid medications also carry a risk of abuse or addiction by either the patient or non-medical users. For these reasons, consideration of non-opioid strategies for pain management is beneficial. While opioids will certainly continue to have a place in pain management despite their disadvantages, the use of non-opioid medication options may limit the amount of opioid necessary or even result in improved pain control. In fact, given that the majority of both acute and chronic pain is thought to be complex and multi factorial, a multi modal analgesic approach is ideal for management. Acetaminophen is typically considered first-line therapy for chronic pain conditions, including osteoarthritis (OA) and chronic pain associated with total knee arthroplasty. However, many times patients are treated inappropriately with opioids instead.
Acetaminophen is considered first-line treatment for many pain conditions because of its safety advantages. Compared with other analgesics available, acetaminophen is associated with very few adverse events and is considered safe to use chronically. Healthcare providers strive to “first do no harm. Therefore, for most chronic pain conditions, a trial of acetaminophen should be used and monitored for effect before initiating other analgesics, including opioids. However, acetaminophen is not without risks. Safety concerns associated with acetaminophen include serious liver damage if ingestion is greater than the recommended total daily dose of 4,000 mg. Long-term high doses of acetaminophen and accidental overdose from inadvertently consuming multiple acetaminophen products are the leading causes of acute liver failure in the U. S. For this reason it is important that the patients who are utilizing acetaminophen chronically for pain are educated on proper dosing and administration, and are aware of any other acetaminophen-containing products they may use. The disadvantage of acetaminophen is that it often cannot provide a sufficient analgesic effect and does not exert a specific anti-inflammatory effect, causing many patients to discontinue or switch therapies.
REFERENCES
Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain United States, 2016. MMWR Recomm Rep. 2016; 65(1):1-49.
Evolution of the Food and Drug Administration approach to liver safety assessment for new drugs:
/in Uncategorized /by adminPlease respond to this post with a minimum of two paragraphs with two references, APA style, and no plagiarism.
-FDA approach for liver safety for new drugs
The food and drug administration initiated a sequence of annual meetings to deal with issues of drug induced liver injury. This was due to approval of two drugs troglitazone and bromfenac that led to significant lethal liver toxicity. In the meetings reviewers of new drugs are invited to the meetings and the meetings are opened to pharmaceutical industry, academic consultants to industry, and food and drug administration (Senior, 2014).. The slides shown in the meetings are posted on the internet and availed to the American association for the study of the liver diseases. This has raised awareness on new drugs that result to liver injury.
The food and drug administration also developed a program called eDISH meaning evaluation of Drug Induced Serious Hepatotoxicity which is useful in examining drug induced liver injury in clinical trial subjects. This has been useful as the food and drug administration has been able to curb hepatotoxicity (Senior, 2014). The food and drug administration however is yet to find a suitable and best way of estimating the probability that a drug in question actually caused the given liver injury. The food and drug administration also carries a yearly educational conference on drug induced liver injury for the food and drug administration reviewers.
Reference
Senior, J. R. (2014). Evolution of the Food and Drug Administration approach to liver safety assessment for new drugs: current status and challenges. Drug safety, 37(1), 9-17.
What are the roadblocks that hinder HIS Application adoption?
/in Uncategorized /by adminDespite its data-intensive nature, much of the global health care delivery community has yet to convert to fully digital HIS (Healthcare Information Systems) Applications for managing information. Significant challenges exist across the entire delivery continuum for converting to HIS Applications, not the least of which is having a process. Software initiatives involving the development of a complex system such as an HIS Application are best constructed within the framework of a system life cycle. Read Chapter 3 (file uploaded). 1. Explain. 2. Why should there be an ongoing examination of an HIS Application versus moving to other applications that are newly developed or marketed? Explain. Note: Do not write introduction & conclusion. Do not plagiarize. You can research on the Internet or books/journals & you can add additional references.
U.S Elite Tutors
U.S Elite Tutors is a leading academic writing company, which has been providing exclusive writing services for years. We are here to help you write any paper on our new website 24/7.
Writing Services
/
Contact Info
For any questions, feedback, or comments, we have an ethical customer support team that is always waiting on the line for your inquiries.
